This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
Vaccinating whole communities with the malaria vaccine R21 before the rainy season, alongside existing malaria control tools, can reduce the odds of infection by up to 70%, according to a new study published in The Lancet.
The study was conducted in The Gambia, where malaria is seasonal with low-to-moderate transmission, and in Burkina Faso, where transmission is intense. It found that seasonal mass vaccination with the R21/Matrix-M (R21) vaccine, given to entire communities ahead of the rainy season, significantly reduced the proportion of individuals infected with malaria at peak transmission in November in both countries. It also reduced the number of patients with clinical malaria by 47% in The Gambia and 30% in Burkina Faso.
This is the first study that vaccinated whole communities against malaria with a vaccine, R21, that is used in small children. Seasonal mass vaccination can become a vital additional tool to reduce the burden of malaria and help in progressing toward elimination efforts.
Malaria continues to be life-threatening in many communities. Children under 5, pregnant women and people living with HIV or AIDS are at higher risk of severe infection. But global progress against malaria has stalled over the past decade, with cases and deaths well above the levels needed to reach elimination targets.
Umberto D'Alessandro, professor and principal investigator of the SERVAL study at MRC Unit The Gambia at London School of Hygiene & Tropical Medicine, said, "The study clearly shows that R21 can decrease malaria in older children, adolescents and adults, disproving previous assumptions that the vaccine would not be effective in these age groups.
Source link







